Your browser is no longer supported. Please, upgrade your browser.
ABBV [NYSE]
AbbVie Inc.
IndexS&P 500 P/E29.00 EPS (ttm)3.71 Insider Own0.12% Shs Outstand1.77B Perf Week0.98%
Market Cap191.43B Forward P/E7.71 EPS next Y13.97 Insider Trans-4.76% Shs Float1.76B Perf Month-8.15%
Income6.60B PEG6.20 EPS next Q3.24 Inst Own68.70% Short Float0.77% Perf Quarter-4.76%
Sales53.73B P/S3.56 EPS this Y-48.50% Inst Trans-0.23% Short Ratio1.97 Perf Half Y4.17%
Book/sh7.11 P/B15.15 EPS next Y10.74% ROA4.40% Target Price125.96 Perf Year20.19%
Cash/sh4.84 P/C22.26 EPS next 5Y4.68% ROE48.30% 52W Range79.11 - 121.53 Perf YTD0.54%
Dividend5.20 P/FCF17.83 EPS past 5Y-2.80% ROI12.70% 52W High-11.36% Beta0.81
Dividend %4.83% Quick Ratio0.80 Sales past 5Y14.90% Gross Margin65.70% 52W Low36.18% ATR2.48
Employees48000 Current Ratio0.90 Sales Q/Q33.90% Oper. Margin28.90% RSI (14)34.67 Volatility1.86% 2.37%
OptionableYes Debt/Eq6.53 EPS Q/Q191.90% Profit Margin12.30% Rel Volume1.96 Prev Close108.08
ShortableYes LT Debt/Eq5.91 EarningsJul 30 BMO Payout133.00% Avg Volume6.86M Price107.73
Recom2.00 SMA20-5.36% SMA50-6.76% SMA200-2.82% Volume13,463,708 Change-0.32%
Jul-27-21Resumed Truist Buy $118
Apr-07-21Resumed RBC Capital Mkts Outperform $135
Nov-10-20Resumed Bernstein Outperform $120
Sep-29-20Initiated Berenberg Hold $98
Jun-23-20Upgrade Atlantic Equities Neutral → Overweight $115
Jun-09-20Upgrade Wolfe Research Peer Perform → Outperform
Jun-02-20Upgrade Argus Hold → Buy $115
May-18-20Resumed BofA/Merrill Neutral $95
May-12-20Upgrade JP Morgan Neutral → Overweight $105
May-11-20Resumed Morgan Stanley Overweight $95
Apr-20-20Upgrade RBC Capital Mkts Sector Perform → Outperform $79 → $93
Mar-23-20Downgrade Societe Generale Buy → Hold
Feb-27-20Initiated Barclays Equal Weight $97
Feb-06-20Initiated Mizuho Buy
Jan-07-20Initiated RBC Capital Mkts Sector Perform $86
Dec-26-19Reiterated Cowen Outperform $90 → $98
Sep-26-19Upgrade Citigroup Neutral → Buy $87 → $90
Aug-20-19Upgrade Piper Jaffray Neutral → Overweight $80
Jun-27-19Upgrade Wolfe Research Underperform → Peer Perform
Jun-26-19Upgrade SVB Leerink Mkt Perform → Outperform $88
Sep-18-21 05:57AM  
Sep-17-21 01:17PM  
12:10PM  
09:11AM  
07:40AM  
Sep-16-21 12:42PM  
09:05AM  
08:00AM  
Sep-15-21 11:00AM  
Sep-14-21 05:45PM  
11:21AM  
10:55AM  
10:45AM  
10:24AM  
07:52AM  
Sep-13-21 04:06PM  
02:40PM  
10:57AM  
10:10AM  
08:39AM  
08:25AM  
07:13AM  
06:30AM  
Sep-10-21 12:19PM  
10:27AM  
09:55AM  
09:00AM  
Sep-09-21 11:30AM  
08:00AM  
07:00AM  
07:00AM  
Sep-08-21 05:45PM  
11:45AM  
09:10AM  
Sep-07-21 01:31PM  
Sep-06-21 11:47AM  
Sep-03-21 10:06AM  
06:21AM  
Sep-02-21 03:04PM  
01:34PM  
11:34AM  
09:17AM  
08:34AM  
06:02AM  
03:17AM  
Sep-01-21 04:05PM  
03:55PM  
03:48PM  
12:19PM  
05:52AM  
Aug-31-21 01:25PM  
10:00AM  
Aug-30-21 01:31PM  
Aug-29-21 06:48AM  
Aug-28-21 06:06AM  
Aug-27-21 01:10PM  
07:19AM  
06:12AM  
05:52AM  
Aug-26-21 03:55PM  
10:01AM  
09:34AM  
05:55AM  
Aug-25-21 11:35AM  
09:53AM  
Aug-24-21 05:24PM  
08:00AM  
Aug-23-21 01:41PM  
11:45AM  
08:08AM  
Aug-21-21 11:36AM  
Aug-20-21 03:48PM  
Aug-19-21 01:08PM  
10:06AM  
Aug-18-21 05:28PM  
10:07AM  
09:48AM  
07:15AM  
Aug-17-21 06:28AM  
02:12AM  
Aug-16-21 07:19PM  
05:16PM  
Aug-15-21 11:00PM  
Aug-13-21 06:22AM  
02:00AM  
Aug-11-21 03:24PM  
06:22AM  
Aug-10-21 06:35AM  
Aug-09-21 04:27PM  
10:57AM  
08:45AM  
Aug-06-21 11:52AM  
11:45AM  
10:20AM  
Aug-04-21 02:43PM  
12:01PM  
10:32AM  
03:15AM  
Aug-02-21 06:18PM  
05:21PM  
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behcet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenstrom's macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; AndroGel for males diagnosed with symptomatic low testosterone; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production. The company was incorporated in 2012 and is based in North Chicago, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sorg Elaine K.SVP, US Commercial OperationsAug 23Option Exercise114.367,080809,66918,675Aug 25 06:08 PM
Sorg Elaine K.SVP, US Commercial OperationsAug 23Sale120.0013,0801,569,60011,595Aug 25 06:08 PM
Strom Carrie CSVP & Pres Global Allerg AesthAug 23Sale120.005,057606,84051,047Aug 25 06:08 PM
SALEKI-GERHARDT AZITAEVP, OperationsMay 24Option Exercise34.9386,9203,036,230203,204May 26 05:20 PM
SALEKI-GERHARDT AZITAEVP, OperationsMay 24Sale116.2986,92010,108,033116,284May 26 05:20 PM
Strom Carrie CSVP & Pres Global Allerg AesthMay 03Option Exercise41.394,184173,17663,409May 05 04:23 PM
Strom Carrie CSVP & Pres Global Allerg AesthMay 03Sale112.404,184470,28259,225May 05 04:23 PM
GONZALEZ RICHARD AChairman of the Board and CEOMar 02Option Exercise54.86170,1139,332,399546,710Mar 02 08:27 PM
GONZALEZ RICHARD AChairman of the Board and CEOMar 01Sale108.61170,11318,476,204376,597Mar 02 08:27 PM
Stewart Jeffrey RyanSVP, US Commercial OperationsMar 01Sale108.5913,7731,495,57650,969Mar 02 08:26 PM
RICHMOND TIMOTHY J.EVP, Chief HR OfficerMar 01Sale108.5919,5142,119,0410Mar 02 08:31 PM
Sorg Elaine K.SVP, US Commercial OperationsMar 01Sale108.618,440916,64217,595Mar 02 08:30 PM
Sorg Elaine K.SVP, US Commercial OperationsFeb 22Option Exercise89.7820,1951,813,05252,946Feb 24 06:28 PM
Sorg Elaine K.SVP, US Commercial OperationsFeb 22Sale104.7220,1952,114,73232,751Feb 24 06:28 PM
Stewart Jeffrey RyanEVP, Commercial OperationsDec 29Option Exercise51.4225,2901,300,41276,259Dec 31 01:15 PM
Stewart Jeffrey RyanEVP, Commercial OperationsDec 29Sale105.0025,2902,655,45050,969Dec 31 01:15 PM
RICHMOND TIMOTHY J.EVP, Chief HR OfficerNov 27Option Exercise51.4251,9902,673,32651,990Dec 01 05:22 PM
RICHMOND TIMOTHY J.EVP, Chief HR OfficerNov 27Sale105.0051,9905,458,9500Dec 01 05:22 PM
Gosebruch Henry OEVP, Chief Strategy OfficerNov 20Sale99.3840,0003,975,04620,006Nov 24 05:34 PM
ALBAN CARLOSVice ChairmanNov 16Option Exercise35.88115,8304,155,980230,729Nov 18 05:04 PM
ALBAN CARLOSVice ChairmanNov 16Sale100.00115,83011,583,000114,899Nov 18 05:04 PM
GONZALEZ RICHARD AChairman of the Board and CEONov 12Option Exercise57.12194,15411,089,858512,796Nov 12 05:54 PM
GONZALEZ RICHARD AChairman of the Board and CEONov 12Sale97.10194,15418,851,790318,642Nov 12 05:54 PM
SALEKI-GERHARDT AZITAEVP, OperationsNov 10Sale98.0017,4261,707,74896,441Nov 12 05:56 PM
GONZALEZ RICHARD AChairman of the Board and CEONov 09Sale95.7437,4503,585,463318,642Nov 12 05:54 PM
SALEKI-GERHARDT AZITAEVP, OperationsNov 04Sale93.614,800449,328109,067Nov 06 04:29 PM
SEVERINO MICHAELVice ChairmanNov 04Sale93.6190,6798,488,46167,281Nov 06 04:29 PM